Chris Viehbacher will replace Gerard Le Fur as CEO of Sanofi-Aventis.
Johnson & Johnson Vice Chairman Christine Poon will retire in March.
NeurAxon has appointed Thomas Lategan, DPhil as Vice President of Regulatory Affairs.
Cytochroma has selected Steven I. Engel as Vice President of Regulatory Affairs and Quality Assurance.
Varian announced that its Board of Directors has promoted Sean M. Wirtjes, Vice President and Controller, to a new position, Vice President, Finance and Treasurer. Wirtjes assumes the Treasurer position from G. Edward McClammy, who continues as the company's Senior Vice President and CFO.
MediGene has appointed Dr. Hans Joachim Bochtler as Vice President, Clinical Research & Development.
Robert Diegelmann will lead Oxygen Biotherapeutics' new wound care division.
Seigo Izumo, MD hsa joined Gilead Sciences as Senior Vice President, Cardiovascular Therapeutics
ThermoGenesis as appointed Moni Shavit Vice President of R&D.
Genentech has appointed Morgan Sheng, M.D., Ph.D., to Vice President, Neuroscience.
J. Michael French, CEO of MDRNA, has been appointed to the company's Board of Directors and will become President as of October 1, 2008.
David Hsia has joined Kinex Pharmaceuticals' Board of Directors.